In VitroSelection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker

Nucleic Acid Therapeutics - United States
doi 10.1089/nat.2013.0423
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

In Vitroselection and Characterization of RNA Aptamers Binding Thyroxine Hormone

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2007English

In Vitroselection of DNA Aptamers Binding Pesticide Fluoroacetamide

Bioscience, Biotechnology and Biochemistry
Organic ChemistryApplied MicrobiologyMolecular BiologyBiochemistryAnalytical ChemistryMedicineBiotechnology
2016English

Evaluation of CD44 and CD133 as Cancer Stem Cell Markers for Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2012English

CD44 Is a Negative Cell Surface Marker for Pluripotent Stem Cell Identification During Human Fibroblast Reprogramming

PLoS ONE
Multidisciplinary
2014English

Stem Cell-Ness: A "Magic Marker" for Cancer

Journal of Clinical Investigation
Medicine
2005English

The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer

Stem Cells International
Cell BiologyMolecular Biology
2016English

Micro RNA Regulation of Cancer Stem Cell Phenotypes

International Journal of Genetic Science
2014English

CD44 Positive/Cd24 Negative (Stem Cell Like Property) Breast Carcinoma Cells as Marker of Tumor Aggression

Medical Journal Armed Forces India
Medicine
2017English

Inhibition of PAI-1 Antiproteolytic Activity Against tPA by RNA Aptamers

Nucleic Acid Therapeutics
BiochemistryMolecular MedicineDrug DiscoveryGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy